These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6851627)

  • 1. Lipid-lowering drugs and low-fat diets.
    Palmer RH
    Curr Concepts Nutr; 1983; 12():101-9. PubMed ID: 6851627
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering.
    Diabetes Obes Metab; 2002 Mar; 4(2):138. PubMed ID: 11993443
    [No Abstract]   [Full Text] [Related]  

  • 3. Diet and coronary heart disease: a review of the committee of diet and heart disease of the National Heart Foundation of Australia.
    Med J Aust; 1979 Sep; 2(6):294-307. PubMed ID: 392275
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of dyslipidemia in adults.
    Ahmed SM; Clasen ME; Donnelly JE
    Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ; Kane JP
    Adv Intern Med; 1997; 42():1-38. PubMed ID: 9048115
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of coronary atherosclerosis.
    Hodis HN; Cashin-Hemphill L; Mack WJ
    Heart Dis Stroke; 1994; 3(4):182-7. PubMed ID: 7921660
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo model for dyslipidemia with diabetes mellitus in hamster.
    Bhatia G; Rizvi F; Saxena R; Puri A; Khanna AK; Chander R; Wulff EM; Rastogi AK
    Indian J Exp Biol; 2003 Dec; 41(12):1456-9. PubMed ID: 15320502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary and pharmacologic therapy of the lipid risk factors. AMA Council on Scientific Affairs.
    Conn Med; 1985 May; 49(5):321-8. PubMed ID: 3891221
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP; Krist A
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid lowering: myth or therapeutic necessity?].
    Dtsch Med Wochenschr; 1998 Oct; 123(40 Suppl):2-8. PubMed ID: 9793486
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of two lipid-lowering, carotenoid-controlled diets on the oxidative modification of low-density lipoproteins in free-living humans.
    Ahuja KD; Ashton EL; Ball MJ
    Clin Sci (Lond); 2003 Sep; 105(3):355-61. PubMed ID: 12780345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid metabolism disorders: diagnosis and treatment. 4: Drug therapy and dietary recommendations. National Cholesterin-Initiative].
    Fortschr Med; 1991 May; 109(16):344-7. PubMed ID: 1855762
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reduction.
    Ballantyne CM
    Am Heart J; 2004 Jul; 148(1 Suppl):S3-8. PubMed ID: 15211326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid disorders: applying new guidelines to your older patients.
    Leaf DA
    Geriatrics; 1994 May; 49(5):35-41. PubMed ID: 8174939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk and treatment of hyperlipoproteinemias].
    Alzamora P; Alegría E; Iglesias I
    Rev Med Univ Navarra; 1990; 34(1):29-30, 32-5, 37-40. PubMed ID: 2096448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viewpoint: Terje R. Pedersen, MD, PhD. Interview by Robert Short.
    Pedersen TR
    Circulation; 2007 Mar; 115(12):f51-2. PubMed ID: 17393574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.